These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 34923958)

  • 1. Improve in-depth immunological risk assessment to optimize genetic-compatibility and clinical outcomes in child and adolescent recipients of parental donor kidney transplants: protocol for the INCEPTION study.
    Lim WH; Adams B; Alexander S; Bouts AHM; Claas F; Collins M; Cornelissen E; Dunckley H; de Jong H; D'Orsogna L; Francis A; Heidt S; Herman J; Holdsworth R; Kausman J; Khalid R; Kim JJ; Kim S; Knops N; Kosmoliaptsis V; Kramer C; Kuypers D; Larkins N; Palmer SC; Prestidge C; Prytula A; Sharma A; Shingde M; Taverniti A; Teixeira-Pinto A; Trnka P; Willis F; Wong D; Wong G
    BMC Nephrol; 2021 Dec; 22(1):416. PubMed ID: 34923958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal compared with paternal donor kidneys are associated with poorer graft outcomes after kidney transplantation.
    Lim WH; McDonald SP; Coates PT; Chapman JR; Russ GR; Wong G
    Kidney Int; 2016 Mar; 89(3):659-65. PubMed ID: 26880459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long term outcomes of transplantation using kidneys from expanded criteria donors: prospective, population based cohort study.
    Aubert O; Kamar N; Vernerey D; Viglietti D; Martinez F; Duong-Van-Huyen JP; Eladari D; Empana JP; Rabant M; Verine J; Rostaing L; Congy N; Guilbeau-Frugier C; Mourad G; Garrigue V; Morelon E; Giral M; Kessler M; Ladrière M; Delahousse M; Glotz D; Legendre C; Jouven X; Lefaucheur C; Loupy A
    BMJ; 2015 Jul; 351():h3557. PubMed ID: 26232393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of de novo HLA donor specific antibodies (HLA-DSA), HLA antibodies (HLA-Ab) and allograft rejection post blood transfusion in kidney transplant recipients.
    Jalalonmuhali M; Carroll RP; Tsiopelas E; Clayton P; Coates PT
    Hum Immunol; 2020 Jul; 81(7):323-329. PubMed ID: 32327243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Graft and patient outcomes of zero-human leucocyte-antigen-mismatched deceased and live donor kidney transplant recipients.
    Lim WH; Gray NA; Chadban SJ; Pilmore H; Wong G
    Transpl Int; 2015 May; 28(5):610-8. PubMed ID: 25689280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal versus paternal living kidney transplant donation is associated with lower rejection in young pediatric recipients: A Collaborative Transplant Study report.
    Engels G; Döhler B; Tönshoff B; Oh J; Kruchen A; Müller I; Süsal C
    Pediatr Transplant; 2022 Feb; 26(1):e14154. PubMed ID: 34612565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transplantation of Kidneys From Hepatitis C Virus-Infected Donors to Hepatitis C Virus-Negative Recipients: One-Year Kidney Allograft Outcomes.
    Molnar MZ; Azhar A; Tsujita M; Talwar M; Balaraman V; Bhalla A; Podila PSB; Kothadia J; Agbim UA; Maliakkal B; Satapathy SK; Kovesdy CP; Nair S; Eason JD
    Am J Kidney Dis; 2021 May; 77(5):739-747.e1. PubMed ID: 33333148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deceased-Donor Acute Kidney Injury and Acute Rejection in Kidney Transplant Recipients: A Multicenter Cohort.
    Reese PP; Doshi MD; Hall IE; Besharatian B; Bromberg JS; Thiessen-Philbrook H; Jia Y; Kamoun M; Mansour SG; Akalin E; Harhay MN; Mohan S; Muthukumar T; Schröppel B; Singh P; Weng FL; Parikh CR
    Am J Kidney Dis; 2023 Feb; 81(2):222-231.e1. PubMed ID: 36191727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adult-size kidneys without acute tubular necrosis provide exceedingly superior long-term graft outcomes for infants and small children: a single center and UNOS analysis. United Network for Organ Sharing.
    Sarwal MM; Cecka JM; Millan MT; Salvatierra O
    Transplantation; 2000 Dec; 70(12):1728-36. PubMed ID: 11152105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eplet mismatch analysis and allograft outcome across racially diverse groups in a pediatric transplant cohort: a single-center analysis.
    Philogene MC; Amin A; Zhou S; Charnaya O; Vega R; Desai N; Neu AM; Pruette CS
    Pediatr Nephrol; 2020 Jan; 35(1):83-94. PubMed ID: 31599339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Kidney Graft Survival Calculator that Accounts for Mismatches in Age, Sex, HLA, and Body Size.
    Ashby VB; Leichtman AB; Rees MA; Song PX; Bray M; Wang W; Kalbfleisch JD
    Clin J Am Soc Nephrol; 2017 Jul; 12(7):1148-1160. PubMed ID: 28596416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eplet Mismatch Load and
    Senev A; Coemans M; Lerut E; Van Sandt V; Kerkhofs J; Daniëls L; Driessche MV; Compernolle V; Sprangers B; Van Loon E; Callemeyn J; Claas F; Tambur AR; Verbeke G; Kuypers D; Emonds MP; Naesens M
    J Am Soc Nephrol; 2020 Sep; 31(9):2193-2204. PubMed ID: 32764139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preformed donor-specific antibodies and risk of antibody-mediated rejection in repeat renal transplantation.
    Tsapepas DS; Vasilescu R; Tanriover B; Coppleson Y; Rekhtman Y; Hardy MA; Dube G; Crew RJ; Ratner LE; Cohen DJ; Mohan S
    Transplantation; 2014 Mar; 97(6):642-7. PubMed ID: 24637863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of the presence of anti-human leukocyte antigen-donor specific antibody in kidney transplant recipients with allograft dysfunction.
    Chung BH; Kim JH; Choi BS; Park CW; Kim JI; Moon IS; Kim YS; Choi YJ; Oh EJ; Yang CW
    Korean J Intern Med; 2018 Jan; 33(1):157-167. PubMed ID: 27764540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody-Mediated Rejection Due to Preexisting versus
    Aubert O; Loupy A; Hidalgo L; Duong van Huyen JP; Higgins S; Viglietti D; Jouven X; Glotz D; Legendre C; Lefaucheur C; Halloran PF
    J Am Soc Nephrol; 2017 Jun; 28(6):1912-1923. PubMed ID: 28255002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and Clinical Impact of Donor-Specific Alloantibody Among Intestinal Transplant Recipients.
    Cheng EY; Everly MJ; Kaneku H; Banuelos N; Wozniak LJ; Venick RS; Marcus EA; McDiarmid SV; Busuttil RW; Terasaki PI; Farmer DG
    Transplantation; 2017 Apr; 101(4):873-882. PubMed ID: 27490417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kidney transplantation in the US: an analysis of the OPTN/UNOS registry.
    Freitas MC
    Clin Transpl; 2011; ():1-16. PubMed ID: 22755397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of donor-specific anti-HLA antibodies and outcome in renal transplant patients treated with a standardized induction regimen.
    Zecher D; Bach C; Staudner C; Böger CA; Bergler T; Banas B; Spriewald BM
    Nephrol Dial Transplant; 2017 Apr; 32(4):730-737. PubMed ID: 28339671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-transplant HLA Antibodies and Delayed Graft Function in the Current Era of Kidney Transplantation.
    Morath C; Döhler B; Kälble F; Pego da Silva L; Echterdiek F; Schwenger V; Živčić-Ćosić S; Katalinić N; Kuypers D; Benöhr P; Haubitz M; Ziemann M; Nitschke M; Emmerich F; Pisarski P; Karakizlis H; Weimer R; Ruhenstroth A; Scherer S; Tran TH; Mehrabi A; Zeier M; Süsal C
    Front Immunol; 2020; 11():1886. PubMed ID: 32983110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretransplant Renal Arterial Vasculopathy of Donor Predicts Poor Renal Allograft Survival.
    Özdemir BH; Özdemir FN; Börcek P; Sercan Ç; Özdemir G; Ayvazoğlu Soy EH; Haberal M
    Exp Clin Transplant; 2018 Mar; 16 Suppl 1(Suppl 1):41-46. PubMed ID: 29527990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.